Rapid onset of good ON time and improvement in motor-state stability in aPD patients after treatment with continuous subcutaneous foslevodopa/foscarbidopa

被引：0
|
作者：
Pahwa, R.
Soileau, M.
Standaert, D.
Fung, V.
Kimber, T.
Malaty, I.
Merola, A.
Epstein, A.
Yan, C.
Alobaidi, A.
Shewale, A.
Fisseha, N.
Jeong, A.
Facheris, M.
Kukreja, P.
Zamudio, J.
Aldred, J.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
754
引用
收藏
页码：S346 / S346
页数：1
相关论文
共 11 条
  • [1] Stability and Predictability of Motor Symptom Control in Patients with Advanced Parkinson's Disease (aPD) Receiving Continuous Subcutaneous Foslevodopa/Foscarbidopa (LDP/CDP)
    Pahwa, R.
    Malaty, I.
    Soileau, M.
    Fung, V.
    Garcia, D. Santos
    Carroll, C.
    Henriksen, T.
    Epstein, A.
    Yan, C.
    Alobaidi, A.
    Shewale, A.
    Spiegel, A.
    Facheris, M.
    Shah, M.
    Kukreja, P.
    Zamudio, J.
    Chaudhuri, K.
    MOVEMENT DISORDERS, 2023, 38 : S44 - S45
  • [2] Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance
    Fung, Victor S. C.
    Aldred, Jason
    Arroyo, Martha P.
    Bergquist, Filip
    Boon, Agnita J. W.
    Bouchard, Manon
    Bray, Sarah
    Dhanani, Sara
    Facheris, Maurizio F.
    Fisseha, Nahome
    Freire-Alvarez, Eric
    Hauser, Robert A.
    Jeong, Anna
    Jia, Jia
    Kukreja, Pavnit
    Soileau, Michael J.
    Spiegel, Amy M.
    Talapala, Saritha
    Tarakad, Arjun
    Urrea-Mendoza, Enrique
    Zamudio, Jorge
    Pahwa, Rajesh
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 10
  • [3] Challenges with Oral Anti-Parkinsonian Medications and Opportunities with Continuous Subcutaneous Infusion (CSCI) Of Foslevodopa/Foscarbidopa (LDP/CDP) for Treatment of Advanced Parkinson's Disease (aPD)
    Aldred, J.
    Soileau, M.
    Yan, C.
    Brion, T.
    Bellenger, A.
    Suh, J.
    O'Donnell, C.
    Kukreja, P.
    Facheris, M.
    Shewale, A.
    Kumar, R.
    MOVEMENT DISORDERS, 2023, 38 : S8 - S9
  • [4] Improvement in Motor Symptoms and Quality of Life in Patients with an Earlier Stage of Advanced Parkinson's Disease Treated with Foslevodopa/Foscarbidopa Subcutaneous 24 Hour Infusion
    Antonini, A.
    Bergmans, B.
    Kern, D.
    Odin, P.
    Bergmann, L.
    Gupta, R.
    Homola, J.
    Shah, M.
    Zamudio, J.
    Standaert, D.
    MOVEMENT DISORDERS, 2023, 38 : S10 - S10
  • [5] Daily Time-Course of Efficacy of Continuous Subcutaneous Infusion of Foslevodopa/foscarbidopa in Advanced Parkinson's Disease Patients from a Phase 1b Study
    Stodtmann, S.
    Rosebraugh, M.
    Robieson, W.
    Facheris, M.
    MOVEMENT DISORDERS, 2020, 35 : S421 - S421
  • [6] Onset-to-treatment time and aneurysmal regression predict improvement of cranial neuropathy after flow diversion treatment in patients with symptomatic internal carotid artery aneurysms
    Akiyama, Ryo
    Ishii, Akira
    Kikuchi, Takayuki
    Okawa, Masakazu
    Yamao, Yukihiro
    Abekura, Yu
    Ono, Isao
    Sasaki, Natsuhi
    Tsuji, Hirofumi
    Imamura, Hirotoshi
    Hatano, Taketo
    Sakai, Nobuyuki
    Miyamoto, Susumu
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2023, 15 (09) : 886 - 891
  • [7] Duration of continuous "Good On" intervals and number of motor fluctuations after treatment with IPX203 vs immediate-release carbidopa-levodopa in Parkinson's disease patients with motor fluctuations
    Hauser, R.
    Fernandez, H.
    Aldred, J.
    Singer, C.
    Shill, H.
    Factor, S.
    Visser, H.
    D'Souza, R.
    MOVEMENT DISORDERS, 2022, 37 : S331 - S331
  • [8] Differential time and related appearance of signs, indicating improvement in the state of consciousness in vegetative state traumatic brain injury (VS-TBI) patients after initiation of dopamine treatment
    Krimchansky, BZ
    Keren, O
    Sazbon, L
    Groswasser, Z
    BRAIN INJURY, 2004, 18 (11) : 1099 - 1105
  • [9] Good Glycemic Control Is Positively Associated with the Levels of Serum Albumin and Postprandial C-Peptide after Long-Term Continuous Subcutaneous Insulin Infusion Treatment in Patients with Type 2 Diabetes
    Choi, Soo-Bong
    Noh, Yun-Hee
    Lee, Jun-Ho
    Lee, Ju-Han
    Kim, Seonguk
    DIABETES, 2011, 60 : A590 - A590
  • [10] Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial
    Yuan, Guoyue
    Hu, Hao
    Wang, Su
    Yang, Qichao
    Yu, Shuqin
    Sun, Wenjun
    Qian, Weiyun
    Mao, Caoming
    Zhou, Libin
    Chen, Dezhi
    Wang, Zhaoling
    Gong, Qin
    Wang, Dong
    ENDOCRINE JOURNAL, 2015, 62 (09) : 817 - 834
12